Explore Past Issues of MedTech Strategist

With more than 100 years of collective experience, our subject matter experts have designed MedTech Strategist as an indispensable resource for you, and your entire organization.

Coming on its 5th year, MedTech Strategist has published an impressive 78 issues and 575 articles.

Think Strategically.  Subscribe Today.

Issue: Vol. 5, No. 14 - October 17, 2018

  • “MD Start: Building Medtech Companies in Europe,” by David Cassak

  • “Regulatory Shifts for HCT/P Products Put Orthobiologics Manufacturers on the Spot,” by Wendy Diller

  • SIDEBAR: “FDA’s Evolving Criteria for Tissue-based Biologics: Takeaways,” by Wendy Diller

  • SIDEBAR: “MiMedx Wins an Orthopedic Rarity: RMAT Designation for AmnioFix Injectable, “ by Wendy Diller

  •  “Three Strategies to Avoid Medical Device Commoditization,” by Tom Dudnyk, VIVO Agency

  • Start-Ups to Watch—"EmboMedics: Thinking Organically about Embolization,” by Colin Miller

  • Start-Ups to Watch—"Kobara Medical: Epicardial Pacing Provides Advantages for Heart Failure Patients,” by Mary Stuart

Issue: Vol. 5, No. 13 - September 28, 2018

  • “SpineGuard: Riding Robotics’ Wave,” by David Cassak

  • “Atrial Fibrillation Part 2: New Mapping, Information Systems Lay Down Evidence Base,” by Mary Stuart

  • SIDEBAR: “Kardium Tackles the AF Problem from Scratch,” by Mary Stuart

  • “Digital Taps Into Neurological Function,” by Mark Ratner

  • “Digital Technologies Shake Up Arrhythmia Monitoring, Part 1: Apple’s New ECG-Enabled Watch—Gizmo or Game Changer?” by Mary Thompson

  • Start-Ups To Watch —“PathMaker Neurosystems: A Non-Invasive Bioelectronic Platform Restores Neuromotor Function,” by Mary Stuart

  • Start-Ups To Watch — “Perflow Medical: Next-Gen Products for a Booming Neurovascular Market,” by Mary Stuart

Issue: Vol. 5, No. 12 - September 14, 2018

  • “Orthobiologics at a Crossroads,” by Wendy Diller

  • SIDEBAR: “KOA Clinical Trials May Soon Provide Some Insights,” by Wendy Diller

  • “ CGM on the Upswing: A Three-Month Implantable Enters the Fray,” by Mary Thompson

  • SIDEBAR: “Senseonics Expands the CGM Toolbox with a 90-Day Implantable: CEO Tim Goodnow Charts the Path Forward” by Mary Thompson

  • “Is Medtech Too White?” By Kwame Ulmer

  • Start-Ups To Watch - “Neuromod Devices: Targeting Tinnitus Discreetly and Effectively,” by Colin Miller

  • Start-Ups To Watch - “Transverse Medical: Total Protection for the Brain During TAVR,” by Mary Stuart  

Issue: Vol. 5, No. 11 - August 24, 2018

  • “As the Digital Revolution Sweeps Healthcare, Don’t Shortchange IVD,” by Wendy Diller

  • “Carbon: Bringing a Revolution to the 3D Revolution,” by David Cassak + Sidebar:  “A Play for Johnson & Johnson”

  • “Atrial Fibrillation Ablation After CABANA: What Are We Missing?,” by Mary Stuart + Sidebar: “CABANA Results in Confusion, Not Clarity”

  • “Companies See Big Opportunity for AI-Assisted Imaging in Stroke,”  by Varun Saxena

  • “Medtech US IPO Window Finally Re-opens; Financial Buyers Return to M&A Market,” by Stephen Levin

  • Start-Ups To Watch - “AblaCare: Infertility Treatment Made Safer,” by Colin Miller

  • Start-Ups To Watch - “Carmentix:  A Biomarker-Based Approach to the Global Problem of Preterm Births,” by Mary Stuart

Issue: Vol. 5, No. 10 - July 26, 2018

  • In Memoriam— “Sami Hamadé: Medtech Coach, Inspiration, and Investor,” by David Cassak

  • Executive Interviews - “Finding Success in China: The Biosensors Story,” by David Cassak

  • Reproductive Medicine - “How Genomics, Big Data, and Consumerism are Bringing Entrepreneurial Opportunities to Infertility,” by Wendy Diller

  • Digital Health - “Virtual Reality Enters Physician Training: A Conversation with Sandra Humbles and David Badri of the Johnson & Johnson Institute,” by Mary Thompson

  • Outside Opinion - “Beware the Seductions of M&A,” by Mark Speers, Health Advances

  • Start-Ups to Watch – “Neurent Medical: An Office-Based Procedure Treats Rhinitis,” by Mary Stuart

  • Start-Ups to Watch—“Univfy: Personalized Prognostics for Successful, Accessible IVF Treatment,” by Wendy Diller


Issue: Vol. 5, No. 9 - June 27, 2018

  • “Charting Baxter International Inc.’s Rebound: An Interview with CEO Joe Almeida,” by David Cassak

  • “Orthopedics Grapples with Evidence-Based Use of Stem-Cell Therapies,” by Wendy Diller

  • “Good News, Bad News: Hospitals Want to Partner,” by L.E.K. Consulting's Jonas Funk, Monish Rajpal, and Ilya Trakhtenberg

  • “Driving Medical Device Sales and Profit Growth by Creating Mega-5’s,” by John Larson

  • Start-Ups To Watch – “ Output Medical, Inc.: Predicting Acute Kidney Injury Right on Time,” by Colin Miller

  • Start-Ups To Watch – “SentiAR: Intraprocedural, Real-Time Augmented Reality Enhances Catheter Ablation,” by Mary Stuart

Issue: Vol. 5, No. 8 - June 8, 2018

  • Managing in Interesting Times: An Interview with Paul LaViolette,” by David Cassak

  • “In Medtech, Real-World Evidence is Moving Beyond Theory to Regulatory Use,” by Wendy Diller

  • “ResMed Using Digital Health to Fuel a Medtech Growth Strategy,” Mary Stuart

  • “Digital Innovation: Consumer Activation Comes of Age in Medtech,” by Ajay Gupta, Karen Passmore, Sundar Ganapathy, and Chris Smith

  • “What’s Next for the Ischemic Stroke Market? Brett Wall, SVP and President of Brain Therapies at Medtronic, Weighs In,” by Mary Thompson

  • Start-Ups To Watch – “Eyenuk, Inc.: Artificial Intelligence Boosts Diabetic Retinopathy Screening by Mary Stuart

  • Start-Ups To Watch - HeartSciences: Artificial Intelligence Improves Frontline Risk Stratification for Heart Diseases,” by Mary Stuart

Issue: Vol. 5, No. 7 - May 29, 2018

  • Perspective – “Funding Gap? What Funding Gap?” by David Cassak

  • Market Disruptors – “Is Amazon’s Healthcare Foray a Threat to the Medtech Market?” by Wendy Diller

  • “Saluda Medical: Will Sensors and Data Disrupt Spinal Cord Stimulation?” by Mary Stuart

  • “Crossing the High-Tech, ‘Wet Science’ Divide” by Wendy Diller

  • “Solving the Prisoner’s Dilemma: Product Innovation, Solutions-Focused Business Models Can Help Counter Declining Medtech ROC” by Yakir Siegal, Glenn Snyder, Myriam Lopez, Lauren Morton

  • Stroke Devices – “Neurovascular Device Market Poised for Growth” by Oded Ben-Joseph and Seth Bensussen

  • Start-Ups To Watch: “CroiValve: Solution for Tricuspid Regurgitation Supports the Native Valve” by Mary Stuart

  • Start-Ups To Watch: “ChromaCode: Disrupting Molecular Diagnostics in the Digital Age” by Wendy Diller

Issue: Vol. 5, No. 6 - May 11, 2018

  • Executive Interview - “ExploraMed: Patient Need, Stakeholder Perspective Guide Solution Design,” by David Cassak

  • Surgical Pain Management - “Spine Surgeons Confront the Opioid Crisis,” by Wendy Diller

  • Q1 M&A/Financing Wrap-Up - “Despite Optimistic Outlook, M&A Dries Up and IPOs Remain Non-Existent,” by Stephen Levin

  • Market Brief: Orthopedics - “Early Q1 Data Shows Pressure on Ortho,” by Wendy Diller

  • Start-Ups To Watch - Tissue Engineering: “ Humacyte’s Bio-engineered Human Blood Vessel Enters Pivotal Trials,” by Mary Stuart

  • Start-Ups To Watch - Peripheral Artery Disease: “XABLECATH LTD Reimagines Peripheral Vascular Care,” by Colin Miller

Issue: Vol. 5, No. 5 - April 20, 2018

  • “Finding Meaningful Value in Medtech: Interview with Alex Gorsky

  • “Navigating New Technologies through Seismic Shifts: Medtech Execs, Investors Weigh In”

  • “Diabetes Devices: The High-Tech Transformation Continues”

  • “Surgical Robotics: The Future is Now”

  • “Coatings Take Center Stage, Scaffolds a Back Seat”

  • “New Data and More Expansive Guidelines Give Ischemic Stroke Market a Push"

  • “MIS Spine: Advances in Visualization, Navigation, and Robotics”

  • “SUs Expand Device Markets for Pain with Peripheral Nerve Stim & Less Invasive Platforms”

  • “Neuros Medical: An Electrical Nerve Block for Chronic Pain”

  • “Neuspera Medical: Least Invasive Platform Increases Attractiveness of Neurostimulation”

  • “VERAFEYE: Improving First-Procedure AF Ablation Success Rates”

Issue: Vol. 5, No. 4 - March 27, 2018

  • “J&J in Medtech: An Interview with CEO, Alex Gorsky”

  • “Why Big Companies Can’t Innovate”

  • “Advanced Tech: A Corporate Incubator”

  • “AI in Healthcare: Applying Sophisticated Analytics to Solve Healthcare’s Biggest Challenges”

  • “Transcatheter Heart Valves: The Year of Big Data”

  • “Opioid Crisis Reframes Device Market for the Treatment of Pain”

  • “Liquid Biopsies: At an Inflection Point?”

  • “Ophthalmic Surgical Device Market: A Mixed Bag"

  • “Raydiant Oximetry: Provides Crucial Comfort for New Mothers”

  • “Infervision: Applying Deep- Learning AI to Imaging Scans to Improve Disease Detection”

  • “Numares Health: Using Physics and Algorithms to Transform Clinical Diagnostics”

  • “ProLung: Risk Stratification Test for Lung Cancer”

Full Issues of MedTech Strategist from 2014-2018

Since 2014, MedTech Strategist has published an impressive 75 issues and 557 articles.
Explore the breadth and depth of our coverage of the medical device industry.

Recently Covered Companies:

Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Medtronic, Abbott Laboratories, Abbott Vascular, AcuFocus, Allergan, Amazon, Analytics 4 Life, Arterys, Baylabs, Biocartis, Biodesix, Cardiac Dimensions, Cardiogram, Deep Mind, Echo Pixel, Endo Pharmaceuticals, Epic Sciences, Exact Sciences, Excel Medical, Exosome Diagnostics, Flatiron Health, Foundation Medicine, Gauss Surgical, GE Healthcare, Genetesis, Glaukos, Google, Genomic Health, Grail, Guardant Health, IBM Watson Health, Illumina, Infervision, Inivata, Intensix, Ivantis, MedyMatch Technology, Mitraltech, Mynosys Cellular Devices, Myriad Genetics, Natera, NeoGenomics, Nevro, Novartis, Numares, Nuvectra, Pathway Genomics, Personal Genome Diagnostics, PowerVision, Presbia, ProLung, Propeller Health, Purdue Pharma, Qiagen, QView Medical, ReVision Optics, Roche, Roche Molecular Systems, RxSight, Santen Pharmaceutical, Sensome, Sentrian, SightLife Surgical, Synaptive Medical, Viz.ai, Zebra Medical Vision, BioMeridian, ProLung, Visio, Raydiant Oximetry

Ablation Frontiers Inc., AppliedVR Inc.,  Becton Dickinson & Co., Biosensors International Group Ltd., Biowink GMBH, Blue Sail Medical Co. Ltd., Boston Scientific Corp., CardioMEMS Inc., Certara LP, GE Medical Systems, GenePeeks Inc., Huawe, Illumina Inc., Intersect ENT, Johnson & Johnson, Johnson & Johnson Institute, Johnson & Johnson Medical Devices Companies, Lepu Medical Technology (Beijing) Co. Ltd., Eli Lilly & Co., Medtronic PLC, MicroPort Scientific Corp.,  Mindray Medical International Ltd., Mitsubishi Chemical Holdings Corp., Modern Fertility, Neurent Medical, Nevro Corp., Novartis AG, NxThera Inc., Oculus VR LLC, Prelude Fertility, PuraCath Medical Inc., Samsung Electronics America Inc., Shandong Weigao Group Medical Polymer Co., Shockwave Medical Inc., Terumo Corp., Tusker Medical Inc., Univfy Inc., 23andme Inc., 3D Systems, Abbott Laboratories Inc., AblaCare, Adidas Inc., Aidoc, Align Technology Inc., Ambry Genetics, Angiodynamics Inc., Becton Dickinson & Co., Bioabsorbable Vascular Solutions, BMW, Boston Scientific Corp., Brainomix, Canon Medical Systems, Carbon Inc., CardioFocus Inc., Carmentix Pte. Ltd., Cerebrotech Medical Systems Inc., Cerner Corp., ELectroCore Inc., Farapulse Inc., FormaLabs, GE Healthcare, General Electric Co., Google, Grupo Fleury, Hologic Inc., IBM Watson Health, Imricor Medical Inc., Infervision, Inspire Medical System Inc.,  Intel Corp., Invitae Corp., iSchemaView Inc., Johnson & Johnson, LifeScan Inc., Liquidia Technologies Inc., MakerBot, Max-Q AI, Medtronic PLC, Neuronetics Inc., Orthopediatrics Corp., Penumbra Inc., Qiagen, Rapid Medical, Roche, Roche Diagnostics Corp., Royal Philips, Samsung Neurologica, Sensome, Stratasys, Stryker Corp., Viewics Inc., Viz.ai, Vyaire Medical, WhatsApp, Zebra Medical Vision

Recently Covered Topics:

Cardiovascular; Vascular; Diagnostics; Health Information Technology; Digital Health; Respiratory;  Neurostimulation; Neuromodulation; Ophthalmology; Pain Management; Surgery; Minimally Invasive Surgery; Robotics; Orthopedics; Medtech Business Strategies; Business Development; Executive Interviews; Perspective; Commentary; Imaging; Oncology; Women’s Health; Oncology; Precision Medicine, Spine; Aesthetics/Dermatology; Reimbursement; Regulatory; Healthcare delivery; Providers; Payors, Neurology; Neurovascular; Critical Care; Emergency Medicine; Medical Devices;  Investments; Finance; M&As; Services And Solutions; Start-Ups; Ear, Nose & Throat, Emerging Markets;